Position in MRK
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$119,505
+$8,718 QoQ
Shares Held
930
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#3,573
of 3,766 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DiNuzzo Private Wealth, Inc. holds $599,622 across 12 Drug Manufacturers - General names. MRK ranks #3 (19.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
133 | $159,524 | |
| 2 | ABBV |
AbbVie Inc.
|
489 | $123,051 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
930 | $119,505 | |
| 4 | JNJ |
Johnson & Johnson
|
428 | $108,699 | |
| 5 | PFE |
Pfizer Inc
|
1,122 | $27,017 | |
| 6 | AMGN |
Amgen Inc
|
46 | $16,657 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
102 | $12,886 | |
| 8 | SNY |
Sanofi
|
299 | $12,755 |
All Filings in MRK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $119,505 | 930 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $110,787 | 921 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $93,681 | 890 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $72,935 | 869 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $68,869 | 870 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $81,143 | 904 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $91,024 | 915 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $116,171 | 1,023 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $128,380 | 1,037 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $132,477 | 1,004 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $109,456 | 1,004 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||